2,815
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Interferon alpha in subacute sclerosing panencephalitis: Case report and review of the literature

, &
Pages 130-134 | Received 23 Jul 2015, Accepted 27 Nov 2015, Published online: 09 May 2016

References

  • Vardas E , Leary PM , Yeats J . Case report and molecular analysis of SSPE in a SA child. J Clin Microbiol. 1999;37:775–777.
  • Garg R . Subacute sclerosing panencephalitis. Postgraduate Med J. 2002;78:63–70.10.1136/pmj.78.916.63
  • Dawson JR . Cellular inclusions in cerebral lesions of epidemic encephalitis. Arch Neurol Psychiatry. 1934;31:685–700.10.1001/archneurpsyc.1934.02250040009001
  • Dixit V , Hettiaratchi E , Muoka T . A study of subacute sclerosing panencephalitis in Kenya. Dev Medicine & Child Neurol. 1981;23:208–16.
  • Tukei P , Kenya P , Ensering H . An epidemiological study of subacute sclerosing panencephalitis in Kenya. East Afr Med J. 1983;60:34–8.
  • Moodie J , Mackenzie D , Kipps A . Subacute sclerosing panencephalitis (SSPE) in southern Africa. S Afr Med J. 1980;58:964–7.
  • Carman W , Johnson S . Subacute sclerosing panencephalitis in South Africa. Trans R Soc Trop Med Hyg. 1989;83:117–8.10.1016/0035-9203(89)90732-3
  • Schoub BD , Johnson S , McAnerney JM . Observations of subacute sclerosing panencephalitis in South Africa. Trans R Soc Trop Med Hyg. 1992;86:550–1.10.1016/0035-9203(92)90106-M
  • McDonald R , Kipps A , Leary P . Subacute sclerosing panencephalitis in the Cape Province. S Afr Med J. (1974);48:7–9.
  • Moodley M , Moosa A . Subacute sclerosing-panencephalitis in black children—A review of 18 CASES. QJM. 1990;76:845–54.
  • Munube G , David J , Kimati V . Subacute sclerosing panencephalitis in Tanzania: Report of a first case. East Afr Med J. 1979;56:347–352.
  • Izuora G , Okoro A , Mordi V . Subacute sclerosing panencephalitis (SSPE) in a Nigerian teaching hospital. East Afr Med J. 1981;58:848–851.
  • Gebremariam A , Lulseged S , Tamrat A . Subacute sclerosing panencephalitis (SSPE) in an adolescent Ethiopian girl. Ann Trop Paediatr. 1987;7:262–3.
  • Kipps A , MacKenzie D , McDonald R . Register of cases of subacute sclerosing panencephalitis (SSPE) in Southern Africa. Cardiovasc Surg. 1977;72:756.
  • Risk WS , Haddad FS . The variable natural history of subacute sclerosing panencephalitis. Arch Neurol. 1979;36:610–4.10.1001/archneur.1979.00500460044004
  • Jones C , Huttenlocher P , Dyken P , et al. Inosiplex therapy in subacute sclerosing panencephalitis. The Lancet 1982;319:1034–7.10.1016/S0140-6736(82)92097-9
  • Haddad FS , Risk WS . Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: A controlled study. Ann. Neurol. 1980;7:185–8.10.1002/(ISSN)1531-8249
  • Gascon GG . Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-α in subacute sclerosing panencephalitis (SSPE): International multicenter study. J Child Neurol. 2003;18:819–27.10.1177/088307380301801201
  • Hara S , Kimura H , Hoshino Y , et al . Combination therapy with intraventricular interferon-α and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay. Brain Develop. 2003;25:367–9.10.1016/S0387-7604(03)00017-2
  • Hosoya M , Shigeta S , Mori S , et al . High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis. Antimicrob Agents Chemother. 2001;45:943–5.10.1128/AAC.45.3.943-945.2001
  • Aydin OF , Senbil N , Kuyucu N , et al. Combined treatment with subcutaneous interferon-α, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis. J Child Neurol. 2003;18:104–8.10.1177/08830738030180020701
  • Anlar B , Gücüyener K , Imir T , et al. Cimetidine as an immunomodulator in subacute sclerosing panencephalitis. Pediatr Infect Dis J. 1993;12:578–81.10.1097/00006454-199307000-00006
  • Yavuz Gürer Y , Kükner Ş , Sarica B . Intravenous γ-globulin treatment in a patient with subacute sclerosing panencephalitis. Pediatr Neurol. 1996;14:72–4.10.1016/0887-8994(95)00257-X
  • Anlar B , Yalaz K , Oktem F , et al. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology. 1997;48:526–8.10.1212/WNL.48.2.526
  • Miyazaki M , Nishimura M , Toda Y , et al . Long-term follow-up of a patient with subacute sclerosing panencephalitis successfully treated with intrathecal interferon alpha. Brain Develop. 2005;27:301–3.10.1016/j.braindev.2004.07.003
  • Panitch H , Gomez-Plascencia J , Norris F , et al. Subacute sclerosing panencephalitis: Remission after treatment with intraventricular interferon. Neurology. 1986;36:562–6.10.1212/WNL.36.4.562
  • Steiner I , Wirguin I , Morag A , et al. Intraventricular Interferon treatment for subacute sclerosing panencephalitis. J Child Neurol. 1989;4:20–4.10.1177/088307388900400103
  • Kurata T , Matsubara E , Yokoyama M , et al . Improvement of SSPE by intrathecal infusion of  -IFN. Neurology. 2004;63:398–9.10.1212/01.WNL.0000130516.54312.A1
  • Horiguchi Y , Ohya T . Successful treatment of subacute sclerosing panencephalitis with long-term intrathecal large dose of alpha-interferon – A case report. No to Hattatsu Brain Develop. 1995;27:231–7.
  • Gowda VK , Sukanya V , Shivananda . Acquired immunodeficiency syndrome with subacute sclerosing panencephalitis. Pediatr Neurol. 2012;47:379–81.10.1016/j.pediatrneurol.2012.06.020
  • Sivadasan A , Alexander M , Patil AK , et al. Fulminant subacute sclerosing panencephalitis in an individual with a perinatally acquired human immunodeficiency virus infection. Arch Neurol. 2012;69:1644–7.10.1001/archneurol.2012.486